Exact Mass: 430.2315
Exact Mass Matches: 430.2315
Found 500 metabolites which its exact mass value is equals to given mass value 430.2315
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Budesonide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D000893 - Anti-Inflammatory Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07E - Intestinal antiinflammatory agents > A07EA - Corticosteroids acting locally R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids COVID info from clinicaltrials, clinicaltrial, clinicaltrial, clinicaltrials, clinical trial, clinical trials CONFIDENCE standard compound; INTERNAL_ID 1169; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9413; ORIGINAL_PRECURSOR_SCAN_NO 9410 CONFIDENCE standard compound; INTERNAL_ID 1169; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9427; ORIGINAL_PRECURSOR_SCAN_NO 9425 CONFIDENCE standard compound; INTERNAL_ID 1169; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9421; ORIGINAL_PRECURSOR_SCAN_NO 9419 CONFIDENCE standard compound; INTERNAL_ID 1169; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9462; ORIGINAL_PRECURSOR_SCAN_NO 9460 CONFIDENCE standard compound; INTERNAL_ID 1169; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9470; ORIGINAL_PRECURSOR_SCAN_NO 9465 CONFIDENCE standard compound; INTERNAL_ID 1169; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9478; ORIGINAL_PRECURSOR_SCAN_NO 9475 CONFIDENCE standard compound; INTERNAL_ID 2822
Budesonide
Budesonide is only found in individuals that have used or taken this drug. It is a glucocorticoid used in the management of asthma, the treatment of various skin disorders, and allergic rhinitis. [PubChem]The exact mechanism of action of budesonide in the treatment of Crohns disease is not fully understood. However, being a glucocorticosteroid, budesonide has a high local anti-inflammatory effect. A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07E - Intestinal antiinflammatory agents > A07EA - Corticosteroids acting locally R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids COVID info from clinicaltrials, clinicaltrial, clinicaltrial, clinicaltrials, clinical trial, clinical trials D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D000893 - Anti-Inflammatory Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
3b,6b-Diangeloyloxy-7(11)-eremophilen-12,8b-olide
3b,6b-Diangeloyloxy-7(11)-eremophilen-12,8b-olide is a constituent of Petasites japonicus (sweet coltsfoot). Constituent of Petasites japonicus (sweet coltsfoot)
Homofukinolide
Constituent of Petasites japonicus (sweet coltsfoot). Homofukinolide is found in giant butterbur and green vegetables. Homofukinolide is found in giant butterbur. Homofukinolide is a constituent of Petasites japonicus (sweet coltsfoot)
Antibiotic CJ 15544
Antibiotic CJ 15544 is found in mushrooms. Antibiotic CJ 15544 is a metabolite of Hericium ramosum. Metabolite of Hericium ramosum. Antibiotic CJ 15544 is found in mushrooms.
Antibiotic CP 412065
Antibiotic CP 412065 is found in mushrooms. Antibiotic CP 412065 is a metabolite of Hericium ramosum. Metabolite of Hericium ramosum. Antibiotic CP 412065 is found in mushrooms.
(22R)-Budesonide
Ingenol mebutate
Nivacortol
Ingenol_mebutate
Ingenol mebutate is a tetracyclic diterpenoid ester obtained by formal condensation of the carboxy group of (2Z)-2-methylbut-2-enoic (angelic) acid with the 3-hydroxy group of ingenol. Used for the topical treatment of actinic keratosis. It has a role as an antineoplastic agent. It is a tetracyclic diterpenoid, a carboxylic ester and a cyclic terpene ketone. It is functionally related to an angelic acid and an ingenol. Ingenol mebutate was approved by the FDA in January 2012, and it is marketed under the name Picato®. Picato gel is indicated for the topical treatment of actinic keratosis. Before approval, ingenol mebutate was called PEP005 as an investigational drug. PEP005 is a selective small molecule activator of protein kinase C (PKC) extracted from the plant Euphorbia peplus, whose sap has been used as a traditional medicine for the treatment of skin conditions including warts and cancer. PEP005 also has potent anti-leukemic effects, inducing apoptosis in myeloid leukemia cell lines and primary AML cells at nanomolar concentrations. Ingenol mebutate is a Cell Death Inducer. The physiologic effect of ingenol mebutate is by means of Increased Cellular Death. Ingenol mebutate is a natural product found in Euphorbia peplus with data available. Ingenol Mebutate is a selective small-molecule activator of protein kinase C (PKC) isolated from the plant Euphorbia peplus with potential antineoplastic activity. Ingenol mebutate activates various protein kinase C (PKC) isoforms, thereby inducing apoptosis in some tumor cells, including myeloid leukemia cells, melanoma cells, and basal cell carcinoma cells. The PKC family consists of signaling isoenzymes that regulate many cell processes including proliferation, differentiation, and apoptosis. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent Ingenol Mebutate is an active ingredient in Euphorbia peplus, acts as a potent PKC modulator, with Kis of 0.3, 0.105, 0.162, 0.376, and 0.171 nM for PKC-α, PKC-β, PKC-γ, PKC-δ, and PKC-ε, respectively, and has antiinflammatory and antitumor activity.
Sonchuside I
Sonchuside H
2-O-beta-D-glucopyranosyl-11alpha,13-dihydro-8-epi-desacetylxanthiuminol
15,16-dehydrosalvileucolide-6,23-lactone-trans-epoxide
1L-myo-inositol 2alpha,4beta-dimethylbutyryl 6beta-senecioyl 1(axial)beta,3alpha,5alpha
(3S)-3-O-(3,4-Diangeloyl-??-D-glucopyranosyloxy)-7-hydroperoxy-3,7-dimethylocta-1,5-diene
3beta-<2-methylbutyryloxy>-6beta-angeloyloxy-10betaH-furoeremophil-9-one
3beta-angeloyloxy-6beta-(3-methylbutanoyloxy)furanoeremophilan-14-al
8,9-Diangeloyl-(8alpha,9beta,10beta)-8,9,10-Trihydroxy-3-longipinen-5-one|8beta,9alpha-Diangeloyloxy-7beta-hydroxy-1-oxo-alpha-longipinen
16beta-Acetoxy-14,15beta-epoxy-3beta-hydroxy-5beta,14beta-card-20(22)-enolid|16beta-Acetoxy-3beta-hydroxy-14,15beta-epoxido-5beta,14beta-card-20(22)-enolid
1alpha,8-bisangeloyloxy-3beta,4beta-epoxy-bisabola-7(14),10-diene
(1R,7R,8S,10R)-7,8,11-trihydroxyguai-4-en-3-one-8-O-beta-D-glucopyranoside
9alpha-hydroxy-6beta-(9-hydroxydeca-2E,4E,6E-trienoyloxy)-5alpha-drim-7-en-11,12-olide|ustusolate B
9alpha-(Angeloyloxy)-7beta-(2-methyl-2,3-epoxybutyryloxy)longipinen-1-on
integric acid
An eremophilane sesquiterpenoid with anti-HIV-1 activity. It is isolated from Xylaria sp. MF6254.
1alpha,8-bissenecioyloxy-3beta,4beta-epoxybisabola-7(14),10-dien-2-one
2-dehydrorastevione|dehydrorastevione|longipin-2-ene-7beta,8alpha,9alpha-triol-1-one 7,8-diangelate
2alpha-hydroxy-17,O-dihydrobrickellidiffusic acid spiro ketal lactone
1beta-O-beta-D-glucopyranosyl-4beta-hydroxyl-5alpha,6beta,11betaH-eudesma-12,6alpha-olide
(17R)-3beta-hydroxy-4beta-acetoxy-8,14beta-epoxy-5alpha-card-20(22)-enolide
methyl (2beta,12beta,19alpha)-1-benzoylaspidospermidin-21-oate|N1-benzoyl-12-demethoxycylindrocarine
1-O-(2?,3?,4?,4?-tetrahydroabscisoyl)-beta-glucopyranose
rel-2R,5S,9S,10R,11R,12-trihydroxy-6(7)-spirovetiven-8-one-9-O-beta-D-glucopyranoside
abiesadine S|methyl 7-oxo-15-hydroxy-8,11,13-abietatriene-18-succinate
1L-myo-inositol 2alpha-isobutyryl 4beta-methylbutyryl 6beta-senecioyl 1(axial)beta,3alpha,5alpha
4-O-beta-D-glucopyranosyl-11alpha,13-dihydro-8-epi-desacetylxanthiuminol
(1beta,7beta,8beta,10beta)-1,8,11-trihydroxy-4-guaien-3-one 11-O-beta-D-glucopyranoside|1beta-hydroxytorilolone 11-O-beta-D-glucopyranoside
10-(2, 3-Epoxy-2-methylbutanoyl), 9-angeloyl-Cinaglabrone|9-Angeloyl-10(2,3-epoxy-2-methylbutyryl)-cinaglabron|9-Angeloyl-10<2,3-epoxy-2-methylbutyryl>-cinaglabron
4alpha(15),11beta(13)-tetrahydroridentin B-1-O-beta-glucopyranoside
1alpha-angeloyloxy-8-senecioyloxy-3beta,4beta-epoxybisabola-7(14),10-dien-2-one
10-Angeloyl-9-(2,3-epoxy-2-methylbutyryl)-cinaglabron|10-Angeloyl-9-<2,3-epoxy-2-methylbutyryl>-cinaglabron|9-(2, 3-Epoxy-2-methylbutanoyl), 10-angeloyl-Cinaglabrone
1alpha-senecioyloxy-8-angeloyloxy-3beta,4beta-epoxybisabola-7(14),10-dien-2-one
Val Ala Ile Glu
C21H34O9_2(1H)-Azulenone, 6-(beta-D-glucopyranosyloxy)-4,5,6,7,8,8a-hexahydro-5-hydroxy-5-(1-hydroxy-1-methylethyl)-3,8-dimethyl
C25H34O6_(1S,3R,3aS,4S,8aR)-1-Acetoxy-3-hydroxy-3-isopropyl-6,8a-dimethyl-1,2,3,3a,4,5,8,8a-octahydro-4-azulenyl 4-methoxybenzoate
(2R,2R,4aS,6R,8aS)-7-formyl-4-hydroxy-6-(hydroxymethyl)-2,5,5,8a-tetramethyl-3,4,4a,5,6,7,8,8a-octahydro-2H,3H-spiro[benzofuran-2,1-naphthalen]-6-yl acetate
Ala Ala Asn Arg
Ala Ala Arg Asn
Ala Asp Ile Ile
Ala Asp Ile Leu
Ala Asp Leu Ile
Ala Asp Leu Leu
Ala Glu Ile Val
Ala Glu Leu Val
Ala Glu Val Ile
Ala Glu Val Leu
Ala Phe Pro Pro
Ala Gly Gln Arg
Ala Gly Arg Gln
Ala Ile Asp Ile
Ala Ile Asp Leu
Ala Ile Glu Val
Ala Ile Ile Asp
Ala Ile Leu Asp
Ala Ile Met Pro
Ala Ile Pro Met
Ala Ile Val Glu
Ala Leu Asp Ile
Ala Leu Asp Leu
Ala Leu Glu Val
Ala Leu Ile Asp
Ala Leu Leu Asp
Ala Leu Met Pro
Ala Leu Pro Met
Ala Leu Val Glu
Ala Met Ile Pro
Ala Met Leu Pro
Ala Met Pro Ile
Ala Met Pro Leu
Ala Asn Ala Arg
Ala Asn Arg Ala
Ala Pro Phe Pro
Ala Pro Ile Met
Ala Pro Leu Met
Ala Pro Met Ile
Ala Pro Met Leu
Ala Pro Pro Phe
Ala Gln Gly Arg
Ala Gln Arg Gly
Ala Arg Ala Asn
Ala Arg Gly Gln
Ala Arg Asn Ala
Ala Arg Gln Gly
Ala Val Glu Ile
Ala Val Glu Leu
Ala Val Ile Glu
Ala Val Leu Glu
Cys Ile Pro Val
Cys Ile Val Pro
Cys Leu Pro Val
Cys Leu Val Pro
Cys Pro Ile Val
Cys Pro Leu Val
Cys Pro Val Ile
Cys Pro Val Leu
Cys Val Ile Pro
Cys Val Leu Pro
Cys Val Pro Ile
Cys Val Pro Leu
Asp Ala Ile Ile
Asp Ala Ile Leu
Asp Ala Leu Ile
Asp Ala Leu Leu
Asp Ile Ala Ile
Asp Ile Ala Leu
Asp Ile Ile Ala
Asp Ile Leu Ala
Asp Leu Ala Ile
Asp Leu Ala Leu
Asp Leu Ile Ala
Asp Leu Leu Ala
Asp Val Val Val
Glu Ala Ile Val
Glu Ala Leu Val
Phe Ala Pro Pro
Phe Pro Ala Pro
Phe Pro Pro Ala
Gly Ala Gln Arg
Gly Ala Arg Gln
Gly Gln Ala Arg
Gly Gln Arg Ala
Gly Arg Ala Gln
Gly Arg Gln Ala
Ile Ala Met Pro
Ile Ala Pro Met
Ile Cys Pro Val
Ile Cys Val Pro
Ile Met Ala Pro
Ile Met Pro Ala
Ile Pro Ala Met
Ile Pro Cys Val
Ile Pro Met Ala
Ile Pro Val Cys
Ile Val Cys Pro
Ile Val Pro Cys
Leu Ala Met Pro
Leu Ala Pro Met
Leu Cys Pro Val
Leu Cys Val Pro
Leu Met Ala Pro
Leu Met Pro Ala
Leu Pro Ala Met
Leu Pro Cys Val
Leu Pro Met Ala
Leu Pro Val Cys
Leu Val Cys Pro
Leu Val Pro Cys
Met Ala Ile Pro
Met Ala Leu Pro
Met Ala Pro Ile
Met Ala Pro Leu
Met Ile Ala Pro
Met Ile Pro Ala
Met Leu Ala Pro
Met Leu Pro Ala
Met Pro Ala Ile
Met Pro Ala Leu
Met Pro Ile Ala
Met Pro Leu Ala
Asn Ala Ala Arg
Asn Ala Arg Ala
Asn Arg Ala Ala
Pro Ala Phe Pro
Pro Ala Ile Met
Pro Ala Leu Met
Pro Ala Met Ile
Pro Ala Met Leu
Pro Ala Pro Phe
Pro Cys Ile Val
Pro Cys Leu Val
Pro Cys Val Ile
Pro Cys Val Leu
Pro Phe Ala Pro
Pro Phe Pro Ala
Pro Ile Ala Met
Pro Ile Cys Val
Pro Ile Met Ala
Pro Ile Val Cys
Pro Leu Ala Met
Pro Leu Cys Val
Pro Leu Met Ala
Pro Leu Val Cys
Pro Met Ala Ile
Pro Met Ala Leu
Pro Met Ile Ala
Pro Met Leu Ala
Pro Pro Ala Phe
Pro Pro Phe Ala
Pro Val Cys Ile
Pro Val Cys Leu
Pro Val Ile Cys
Pro Val Leu Cys
Gln Ala Gly Arg
Gln Ala Arg Gly
Gln Gly Ala Arg
Gln Gly Arg Ala
Gln Arg Ala Gly
Gln Arg Gly Ala
Arg Ala Ala Asn
Arg Ala Gly Gln
Arg Ala Asn Ala
Arg Ala Gln Gly
Arg Gly Ala Gln
Arg Gly Gln Ala
Arg Asn Ala Ala
Arg Gln Ala Gly
Arg Gln Gly Ala
Val Cys Ile Pro
Val Cys Leu Pro
Val Cys Pro Ile
Val Cys Pro Leu
Val Ile Cys Pro
Val Ile Pro Cys
Val Leu Cys Pro
Val Leu Pro Cys
Val Pro Cys Ile
Val Pro Cys Leu
Val Pro Ile Cys
Val Pro Leu Cys
Antibiotic CP 412065
Homofukinolide
3b,6b-Diangeloyloxy-7(11)-eremophilen-12,8b-olide
Ingenol Mebutate
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent Ingenol Mebutate is an active ingredient in Euphorbia peplus, acts as a potent PKC modulator, with Kis of 0.3, 0.105, 0.162, 0.376, and 0.171 nM for PKC-α, PKC-β, PKC-γ, PKC-δ, and PKC-ε, respectively, and has antiinflammatory and antitumor activity.
nivacortol
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
(+/-)-4-O-benzyl-1,2:5,6-di-O-cyclohexylidene-myo-inositol
3-O-BENZYL-1,2,5,6-DI-O-CYCLOHEXYLIDENE-α-D-GLUCOFURANOSE
4-O-BENZYL-1,2:5,6-DI-O-CYCLOHEXYLIDENE-L-MYO-INOSITOL
3,4-Dihydro-7-(4-(4-(1-naphthyl)piperazino)butoxy)-1,8-naphthyridine-2(1H)-one
Progesterone-11-Alpha-Ol-Hemisuccinate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
5-[10-(5-Methoxy-1,5-dioxopentyl)-1,7-dioxa-4,10-diazacyclododec-4-yl]-5-oxopentanoic acid methyl ester
[5,6-dihydroxy-7-(hydroxymethyl)-3,11,11,14-tetramethyl-15-oxo-4-tetracyclo[7.5.1.01,5.010,12]pentadeca-2,7-dienyl] (E)-2-methylbut-2-enoate
D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06B - Chemotherapeutics for topical use
5-hydroxy-5-(2-hydroxypropan-2-yl)-3,8-dimethyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4,6,7,8,8a-hexahydroazulen-2-one
(1S,4R,7S,8aR)-4-{[(2E,4S)-2,4-dimethyloct-2-enoyl]oxy}-8a-methyl-6-oxo-7-(3-oxoprop-1-en-2-yl)-1,2,3,4,6,7,8,8a-octahydronaphthalene-1-carboxylic acid
[1-[(1,2-Dimethyl-3-indolyl)methyl]-4-[[3-(trifluoromethyl)phenyl]methyl]-4-piperidinyl]methanol
(2S,3aR,5aS,7S,9aR)-1,1,3a,4,5a,7,7-heptamethyl-3,6-dioxo-3,3a,4,5,5a,6,7,8,9,9a-decahydro-1H,3H-spiro[[1]benzofuran-2,6-[2]benzoxepine]-5-carboxylic acid
[(3aS,4S,9bS)-4-(hydroxymethyl)-8-[2-(4-methoxyphenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-cyclopentylmethanone
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-1,2-oxazole-3-carboxamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-1,2-oxazole-3-carboxamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-1,2-oxazole-3-carboxamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-5-methyl-3-isoxazolecarboxamide
(1S,2S,4R,6R,8R,9S,11R,12R,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one
asnovolin I
A meroterpenoid with formula C25H34O6 isolated from the fungus Aspergillus novofumigatus. It is an intermediate produced in the biosynthetic pathway leading to the synthesis of novofumigatonin.
Opiranserin (hydrochloride)
Opiranserin (VVZ-149) hydrochloride, a non-opioid and non-NSAID analgesic candidate, is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A), with IC50s of 0.86 and 1.3 μM, respectively. Opiranserin hydrochloride shows antagonistic activity on rP2X3 (IC50=0.87 μM). Opiranserin hydrochloride is development as an injectable agent for the treatment of postoperative pain[1][2][3].
(1s,2s,3s,6r)-2-[(3r)-3-[(3r,5r)-5-(furan-3-yl)-2-oxooxolan-3-yl]butyl]-1,2-dimethyl-7-oxabicyclo[4.1.0]heptan-3-yl (2z)-2-methylbut-2-enoate
6-hydroxy-3,3,7,9-tetramethyl-5-[(2-methylbut-2-enoyl)oxy]-11-oxotricyclo[5.4.0.0²,⁸]undec-9-en-4-yl 2-methylbut-2-enoate
(2r,3r,3ar,4s,7s,7ar)-7,7a-dimethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-4'-methylidene-2'-oxo-hexahydro-1h-spiro[indene-2,3'-oxolan]-3-yl (2z)-2-methylbut-2-enoate
3,5,5,9-tetramethyl-7-[(2-methylbut-2-enoyl)oxy]-2-oxo-4a,6,7,9a-tetrahydro-1h-benzo[7]annulen-6-yl 2,3-dimethyloxirane-2-carboxylate
5-hydroxy-2,6,6,9-tetramethyl-4-[(2-methylbut-2-enoyl)oxy]-11-oxotricyclo[5.4.0.0²,⁸]undec-9-en-3-yl 2-methylbut-2-enoate
(3s,3as,5ar,6r,9r,9as,9bs)-9-hydroxy-3,5a,9-trimethyl-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-naphtho[1,2-b]furan-2-one
(3ar,4r,6s,7r)-7-hydroxy-7-(2-hydroxypropan-2-yl)-1,4-dimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,3a,4,5,6,8-hexahydroazulen-2-one
(1e)-2-[(1s,3s,7e,10s,16r,17r)-3,6,6,10-tetramethyl-2,4,5,15-tetraoxatetracyclo[8.6.1.1³,¹⁶.0¹,¹³]octadeca-7,12-dien-17-yl]ethenyl 3-methylbut-2-enoate
(1s,6r,14r,15s,17r,19s,22s)-10,15,19-trihydroxy-6,14,18,18,22-pentamethyl-7,13-dioxapentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁷,²²]docosa-3,9,11-trien-8-one
5-(3-formyl-2,6-dihydroxy-4-methylphenyl)-3-methyl-1-(1,2,6-trimethyl-3-oxocyclohexyl)pent-3-en-2-yl acetate
2-[(2r,4as,6s,8r,8ar)-8-hydroxy-4a,8-dimethyl-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydronaphthalen-2-yl]prop-2-enoic acid
(2s)-n-[(2s)-1-(acetyloxy)-3-phenylpropan-2-yl]-2-(benzylamino)-3-phenylpropanimidic acid
(1r,2r,3s,4r,5s,6r)-2,4,6-trihydroxy-3,5-bis[(3-methylbutanoyl)oxy]cyclohexyl 3-methylbut-2-enoate
(3r,4s,5s)-5-[(3e)-4,8-dimethyl-6-oxonon-3-en-1-yl]-3-(2-hydroxy-4-methoxybenzoyl)-4,5-dimethyloxolan-2-one
7-(acetyloxy)-2-isopropyl-3-methoxy-4b,8,8-trimethyl-10-oxo-6,7,8a,9-tetrahydro-5h-phenanthren-4-yl acetate
(1r,2r,3s,4s,5s,7s,8r)-5-hydroxy-2,6,6,9-tetramethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-11-oxotricyclo[5.4.0.0²,⁸]undec-9-en-3-yl (2z)-2-methylbut-2-enoate
5-hydroxy-4-{6-hydroxy-5-[(3z)-4-methyl-6-(2,6,6-trimethyl-3-oxocyclohex-1-en-1-yl)hex-3-en-1-yl]-3,6-dihydro-2h-pyran-2-yl}-5h-furan-2-one
5-hydroxy-1,8a-dimethyl-6-oxo-7-(propan-2-ylidene)-2,3,4,8-tetrahydro-1h-naphthalen-2-yl 3-methyl-4-[(2-methylbut-2-enoyl)oxy]but-2-enoate
(1s,7r,8z,12s,13s,14s)-14-(acetyloxy)-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-3,8,16-trien-12-yl propanoate
(3r,3as,4r,11ar)-3,6,10-trimethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-2-oxo-3ah,4h,7h,8h,11h,11ah-cyclodeca[b]furan-3-yl (2z)-2-methylbut-2-enoate
(1s,4r,7s,8ar)-4-{[(2z)-2,4-dimethyloct-2-enoyl]oxy}-8a-methyl-6-oxo-7-(3-oxoprop-1-en-2-yl)-1,2,3,4,7,8-hexahydronaphthalene-1-carboxylic acid
5-{[3-formyl-2,6-dihydroxy-4-(hydroxymethyl)phenyl]methyl}-1,1,5,6-tetramethyl-2,3,6,7,8,8a-hexahydronaphthalen-2-yl acetate
alatoside b
{"Ingredient_id": "HBIN015045","Ingredient_name": "alatoside b","Alias": "NA","Ingredient_formula": "C21H34O9","Ingredient_Smile": "CC12CCC(CC1C(CC(C2)OC3C(C(C(C(O3)CO)O)O)O)(C)O)C(=C)C(=O)O","Ingredient_weight": "430.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "839","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101259955","DrugBank_id": "NA"}